Search
CG7870
go.drugbank.com/drugs/DB04981InvestigationalIt is a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.
MLN-977
go.drugbank.com/drugs/DB05431ExperimentalIt is developed by PharmaEngine to treat asthma and chronic obstructive pulmonary disease.
Mito-4509
go.drugbank.com/drugs/DB05846ExperimentalIt is used to treat Parkinson's Disease, Alzheimer's Disease, Retinal Disorders and other neurologic Disorders.
Tulathromycin A
go.drugbank.com/drugs/DB11474ExperimentalVet approvedIt is marketed by Pfizer Inc. under the tradename Draxxin.
CDX-6512
go.drugbank.com/drugs/DB17841ExperimentalDeveloped by Codexis, it is being investigated for the treatment of homocystinuria And Maple Syrup Urine Disease.[L46651, L46656]
Phytochlorin
go.drugbank.com/drugs/DB19265InvestigationalPhytochlorin is under investigation in clinical trial NCT06311890 (Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(pdt) With Chlorin-e6 in Treating Moderate to Severe Acne
Synonyms: Chlorin e6, Chlorine e6Toloxatone
go.drugbank.com/drugs/DB09245ExperimentalIt acts as a selective and reversible inhibitor of monoamine oxidase-A (MOA) [L1388].
Virginiamycin M1
go.drugbank.com/drugs/DB01669ExperimentalIt is produced by Streptomyces graminofaciens and other bacteria.
Cycloleucine
go.drugbank.com/drugs/DB04620ExperimentalIt is also a specific and reversible inhibitor of nucleic acid methylation and widely used in biochemical experiments.
Cyclic adenosine monophosphate
go.drugbank.com/drugs/DB02527InvestigationalCyclic adenosine monophosphate (cAMP, cyclic AMP or 3'-5'-cyclic adenosine monophosphate) is a molecule that is important in many biological processes; it is derived from adenosine triphosphate (ATP).